Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Condensed Consolidated Statements of Operations and Comprehensive Loss
Revenue	$ 2,196	$ 480
Operating Expenses
Direct costs	2,030	514
Research and development	6,661	3,106
Marketing and sales	795	556
General and administrative	4,022	597
Total operating expenses	13,508	4,773
Operating Loss	(11,312)	(4,293)
Non-operating Income (Expense)
Interest income	201	1
Interest expense	(5)	(222)
Other income	39
Change in fair value of warrant liabilities	710
Loss from change in fair value of embedded derivative liability		(2,680)
Total Non-operating Income (Loss)	945	(2,901)
Pretax Loss	(10,367)	(7,194)
Income tax benefit	(23)	(53)
Net Loss	(10,344)	(7,141)
Other comprehensive loss	(330)
Comprehensive loss attributable to common stockholders	$ (10,674)	$ (7,141)
Basic loss per share	$ (0.06)	$ (0.10)
Diluted loss per share	$ (0.06)	$ (0.10)
Basic weighted average shares outstanding	172,395,717	70,087,539
Diluted weighted average shares outstanding	172,395,717	70,087,539